Gene Query: SLC25A5

Dataset Description Geneva Score
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 115.61
NRDE2 negatively regulates nuclear exosome functions 43.37
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 42.87
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 34.48
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 33.39
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 30.17
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 29.17
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 29.17
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 27.59
An RNA-centric dissection of host complexes controlling flavivirus infection 27.26
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 27.26
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 26.81
Efficient and quantitative high-throughput tRNA sequencing 26.44
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 26.18
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 26.1
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 26.1
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 26.09
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 24.84
Role of microRNAs in the interaction between Salmonella and the host cell 24.43
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 23.86
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 23.84
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 23.43
Sensing self and nonself circular RNAs 22.46
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 22.04
Novel Targeting of Transcription and Metabolism in Glioblastoma 21.92
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 21.55
Differential expression of genes in AD169-infected MRC5. 21.48
Ebola virus (EBOV) infection of ARPE-19 cells 21.33
Mitochondrial dsRNA triggers antiviral signalling in humans 20.99
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 20.85
RNA-sequencing of formalin fixed human primary melanoma tissue 20.84
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 19.66
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 19.66
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 19.61
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 19.52
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 19.36
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 19.35
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 19.35
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 18.87
Ribosomal footprinting of CN34-Parental and CN34-LM1a 18.42
SLAM-seq for K562 endogenous mRNA decay 18.35
Cellular response to hepatitis E virus (HEV) infection 18.22
Ribosomal footprinting of MDA-Parental and MDA-LM2 18.18
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 17.88
mRNA expression profile of Lymphocytes 17.68
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 17.53
Reassessment of Exosome Composition 17.48
Exogenous rescue of KLHL9 in SF210 cell line 17.4
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 17.25
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 17.25
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 17.01
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 17.0
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 16.98
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 16.96
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 16.78
The human blood-nerve barrier transcriptome 16.6
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 16.44
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 16.05
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 15.96
RNA-Seq with and without RNase treatment in PCa cell lines 15.6
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 15.52
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 15.42
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 15.3
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 15.24
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 15.15
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 15.01
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 14.96
Global analysis of enhancer targets: Mosaic-seq 14.95
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 14.73
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 14.49
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 14.49
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 14.28
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 14.23
Global analyses of the effect of different cellular contexts on microRNA targeting 14.23
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 14.1
RNA m5C Methylation in breast cancer using MeRIP-Seq 13.88
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 13.79
Identification of Atrial Fibrillation associated genes and functional non-coding variants 13.73
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 13.68
Microprocessor mediates transcription termination in long noncoding microRNA genes 13.61
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 13.59
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 13.56
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 13.54
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 13.54
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 13.53
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 13.51
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 13.49
RNA sequencing of primary human platelets and in vitro cell lines 13.45
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 13.43
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 13.43
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 13.33
Effect of Influenza virus infection on lncRNA expression in A549 cells 13.3
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 13.21
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 13.15
Transcriptome analysis of CNS leukemia 13.15
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.12
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 13.07
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 13.05
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 13.0
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 12.88
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 12.76
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 12.68
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 12.68
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 12.56
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 12.56
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 12.55
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 12.34
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 12.32
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 12.29
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 12.21
Short and Long RNA sequencing of human mature erythrocytes 12.19
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 12.11
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 12.09
MicroRNA targetome analysis during HCMV infection 12.09
RNA-seq melanoma 12.05
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 12.03
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 12.02
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 12.01
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 12.01
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 11.98
Generation and functional characterization of MDSC-like cells 11.95
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 11.95
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.95
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 11.94
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 11.93
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 11.91
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 11.89
Profiling of escape kinetics of viruses subjected to RNAi 11.86
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 11.86
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 11.83
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 11.82
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 11.73
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 11.66
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 11.63
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 11.48
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 11.45
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 11.39
RNA-seq of resting and activated CD4+ T cells +-JQ1 11.35
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 11.26
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 11.18
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 11.16
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 11.12
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 11.12
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 11.1
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 11.1
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 10.98
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 10.98
PNET animal model: new insights (II) 10.92
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 10.88
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 10.87
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 10.85
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 10.85
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 10.83
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 10.8
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 10.8
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 10.6
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 10.56
Developmental stage specific chromosome architecture in human erythroid cells 10.55
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 10.55
Determination of tRNA aminoacylation levels by high throughput sequencing 10.48
3’ Uridylation Expands miRNA Target Repertoire 10.45
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 10.44
Transcriptional profiles of normal human mature B cells 10.29
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 10.25
Transcription elongation regulates genome 3D structure 10.22
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 10.22
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 10.16
Differentiation enhances Zika virus infection in neuronal brain cells 10.13
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 10.05
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 10.02
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 9.91
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 9.9
HNF1 regulates critical functions of the human epididymis epithelium. 9.9
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.86
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 9.85
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 9.74
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 9.61
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 9.5
Genome-wide discovery of human splicing branchpoints [RNAse] 9.5
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 9.48
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 9.47
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 9.42
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 9.42
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 9.23
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.22
RNA transcriptome analysis during HSV-1 infection 9.21
The interplay between SOX4 and SMAD3 in the context of breast cancer 9.12
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 9.12
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 9.1
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 9.05
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 9.0
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 8.99
The pause-initiation limit restricts transcription activation in human cells 8.98
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 8.97
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 8.97
RNA-seq of MCF10A cells and CAF 8.94
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 8.92
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 8.91
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 8.91
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 8.91
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 8.87
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 8.87
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 8.86
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 8.86
Maturation of human iNSCs 8.85
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 8.84
RNA-sequencing in irradiated and normal A549 cells. 8.81
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 8.81
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 8.8
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 8.77
Gene Expression Profiling of SPOP Knocked Down Cell 8.73
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 8.65
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 8.63
Transcriptome of activated human and mouse MAIT cells 8.62
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 8.61
T47D RNA-seq and ChrRNA-seq data 8.61
Targeted enhancer activation by a subunit of the integrator complex 8.59
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 8.58
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 8.58
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 8.58
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 8.54
Landscape of H3K4me3 in human CD19 cells 8.53
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 8.51
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 8.51
Role for citron kinase in prostate cancer growth 8.49
Transcriptional profiling of microglia; current state of the art and future perspectives 8.43
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 8.43
Role of XRN2 ribonucleolytic activity in RNA metabolism 8.42
mRNA expression profile of Lymphocytes by high-throuput sequencing 8.27
HEK293 Heat-shock experiment 8.21
Zika infected neural stem cells 8.15
Transcriptome analysis of Zika infected neural stem cells 8.15
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 8.15
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 8.15
Genome-wide discovery of human splicing branchpoints 7.95
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 7.93
Unique features and clinical importance of acute alloreactive immune responses 7.89
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 7.78
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.75
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 7.75
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 7.71
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 7.66
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 7.66
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 7.66
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 7.64
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 7.62
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 7.61
U1 snRNP telescripting regulates size-function stratified human genome 7.58
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 7.49
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 7.38
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 7.38
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 7.37
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 7.36
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 7.34
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 7.2
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 7.19
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 7.19
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.19
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 7.11
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 7.1
Gene expression profile of human placenta from T. Cruzi infected mothers 7.03
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 7.03
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 7.0
The transcriptome and chromatin accessbility landscape of mammalian germline 6.99
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.94
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 6.9
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 6.9
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 6.89
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 6.89
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 6.86
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 6.86
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 6.86
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 6.85
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 6.84
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 6.8
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 6.8
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 6.73
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.7
Solid phase chemistry to covalently and reversibly capture thiolated RNA 6.69
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 6.66
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.61
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 6.6
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 6.57
Peptidomimetic blockade of MYB in acute myeloid leukemia 6.57
Effects of rFVIIIFc on human macrophages 6.54
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 6.53
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 6.52
Exploring the RNA landscape of endothelial exosomes 6.52
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 6.51
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 6.48
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 6.45
METTL3 and WTAP 6.42
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 6.37
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 6.29
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 6.29
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 6.26
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.23
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 6.17
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 6.11
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.07
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 6.02
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 5.99
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 5.99
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 5.96
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.9
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 5.86
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 5.81
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 5.8
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 5.8
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 5.76
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 5.73
High-throughput sequencing of PROMPT-enriched samples. 5.65
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 5.54
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 5.54
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.52
UV_24h_GRO-Seq 5.51
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 5.47
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 5.44
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 5.37
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 5.33
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 5.33
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 5.32
Transcriptome analysis reveals differential splicing events in IPF lung tissue 5.32
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 5.28
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 5.19
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.17
RNA-Seq analysis of human colorectal cancer with liver metastasis 5.11
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 5.08
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 5.07
Genome-wide Analysis of Chromatin Interactions in Human Cells 5.06
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 5.0
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 4.91
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 4.86
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 4.84
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.8
Transcriptome analysis of peripheral blood monocytes 4.79
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 4.46
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 4.44
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 4.42
miR-93 Targets in Human Endothelial Cells 4.4
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.33
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.33
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 4.33
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.26
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 4.25
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.25
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.25
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 4.23
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 4.18
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 4.18
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 4.18
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 4.16
p63 controls the enhancer landscape during keratinocyte differentiation 4.14
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.1
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.1
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 4.09
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 4.04
MicroRNA-125a-5p overexpression in human macrophages 4.04
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 4.04
An optimization system for isolating and sequencing of single human colon cancer cells 3.97
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.97
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 3.92
Transcriptome-wide response to synthetic chromatin protein PcTF 3.89
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 3.86
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.79
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 3.64
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 3.58
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 3.58
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 3.48
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.43
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.43
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.43
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.37
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 3.33
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.26
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.21
Retinoic acid suppresses MYB in adenoid cystic carcinoma 3.19
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 3.19
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.06
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.99
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 2.94
Role of cervicovaginal microbiota in genital inflammation 2.94
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 2.93
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.93
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 2.91
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 2.91
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 2.91
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.9
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.9
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.89
Aneuploidy-induced cellular stresses limit autophagic degradation. 2.86
Differential responses of human fetal brain neural stem cells to Zika virus infection 2.76
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.68
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.68
The bromodomain protein BRD4 regulates splicing during heat shock 2.64
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.62
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 2.6
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.58
Metastasis in triple-negative breast cancer 2.55
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.55
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 2.5
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 2.48
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.44
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.39
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.39
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.38
High-resolution comparative analysis of great ape genomes 2.37
Enhancer activation during EGF response 2.37
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.36
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.36
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 2.35
Human cells contain natural double-stranded RNAs with potential regulatory capacity 2.31
A single-cell transcriptome atlas of the human pancreas 2.29
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.2
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 2.19
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 2.19
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 2.18
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 2.14
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 2.13
Determining mRNA half-lives on a transcriptome-wide scale 2.13
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.11
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 2.08
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 2.07
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 2.04
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.04
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.95
Differential gene expression profiles in imatinib-resistant cell lines 1.93
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.89
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.89
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.88
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.83
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.82
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 1.8
Zika virus directly infects human peripheral neurons and induces cell death 1.76
Total RNA-Seq data from leukemic patients with complex structural variants 1.69
Transposon-based construction of strand-specific RNA-seq libraries 1.67
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.66
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.6
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 1.55
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.54
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.54
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.52
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.5
Toxoplasma gondii infection of human retinal pigment epithelial cells 1.45
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.42
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.41
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.41
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 1.4
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.4
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 1.35
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.33
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.3
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.25
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.25
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.24
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 1.22
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.15
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.15
Transcriptome of human white and brown adipose tissue biopsies 1.13
Global transcriptome analysis of WT versus HEB-/- hESCs 1.07
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 1.06
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.05
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 1.02
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.01
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.01
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.98
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.98
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.94
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.84
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.83
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.83
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.83
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 0.82
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.64
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.63
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.63
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.6
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.56
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.56
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.55
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.53
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 0.53
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.52
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.45
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.44
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.4
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.38
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.35
Gene expression alterations of pancreatic intraepithlial neoplasia 0.29
EGR1-controlled transcriptome of T HESCs 0.27
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 0.25
Myc activation coordinates gene transcription and protein translation responses 0.25
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.24
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.16
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.15
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.12
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.07
Dermal endothelial cells of type 2 diabetic patients 0.04
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.0
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation